Earnings roundup

Several companies with Utah connections reported quarterly financial results this week.

Omniture

Omniture Inc., whose business software is used by Wal-Mart Stores Inc. and Vodafone Group Plc, reported a wider fourth-quarter loss because of stock compensation and acquisition costs.

The loss widened to $1.8 million, or 3 cents a share, from $800,000, or 2 cents, a year earlier, the Orem-based company said Thursday. Sales rose 84 percent to $43.1 million. Profit excluding the costs was 7 cents a share, missing the 8-cent average estimate of analysts surveyed by Bloomberg.

Omniture, whose shares more than doubled last year, fell $2.13, or 8.3 percent, to close at $23.60 in Nasdaq Stock Market composite trading before the earnings announcement. The shares have fallen 29 percent this year.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc., based in Massachusetts, on Wednesday reported fourth-quarter net income of $239.8 million, or 54 cents per share. That compares with $25.3 million, or 8 cents per share.

Revenues were a company-record $2.62 billion, up from $1.67 billion in the year-earlier quarter.

For the full year 2007, the company reported net income of $761.1 million, or $1.72 per share, on revenues of $9.74 billion. That compares with $168.9 million, or 84 cents per share, on revenues of $2.21 billion in 2006.

The company noted that the year-over-year increases were due primarily to Thermo Scientific merging with Fisher Scientific in November 2006.

Thermo Fisher Scientific said in September it would build an $11.4 million BioCenter in Logan to manufacture containers used in the life-science research, biotechnology and pharmaceutical industries. It already has an existing Thermo Scientific HyClone Bioprocess product business unit in Logan.

Myriad Genetics

Biopharmaceutical company Myriad Genetics Inc., based in Salt Lake City, on Tuesday reported a net loss of $5.1 million, or 11 cents per share, for the second fiscal quarter ended Dec. 31. That compares with a loss of $8.8 million, or 22 cents per share, for the same quarter a year earlier.

Revenues totaled $56.7 million, up from $37.1 million in the year-earlier quarter.

At the end of the quarter, the company had about $303 million in cash, cash equivalents and marketable investment securities. The company had no debt and no convertible securities.